Aptevo Therapeutics Inc. - 8-K Filing
Aptevo Therapeutics filed a prospectus supplement for an aggregate offering price of up to $2,309,834 in common stock under its existing At The Market (ATM) Offering Agreement. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)